ATA266377A - METHOD FOR ENRICHING A PLAZENTA-SPECIFIC PROTEIN PP 5 - Google Patents

METHOD FOR ENRICHING A PLAZENTA-SPECIFIC PROTEIN PP 5

Info

Publication number
ATA266377A
ATA266377A AT266377A AT266377A ATA266377A AT A266377 A ATA266377 A AT A266377A AT 266377 A AT266377 A AT 266377A AT 266377 A AT266377 A AT 266377A AT A266377 A ATA266377 A AT A266377A
Authority
AT
Austria
Prior art keywords
plazenta
enriching
specific protein
protein
specific
Prior art date
Application number
AT266377A
Other languages
German (de)
Other versions
AT362057B (en
Original Assignee
Behringwerke Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Behringwerke Ag filed Critical Behringwerke Ag
Publication of ATA266377A publication Critical patent/ATA266377A/en
Application granted granted Critical
Publication of AT362057B publication Critical patent/AT362057B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4715—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Reproductive Health (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Hematology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Endocrinology (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Toxicology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT266377A 1976-04-17 1977-04-15 METHOD FOR ENRICHING THE PLAZENTA-SPECIFIC PROTEIN PP 5 AT362057B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2616984A DE2616984C3 (en) 1976-04-17 1976-04-17 Method for the isolation and purification of a placenta-specific glycoprotein

Publications (2)

Publication Number Publication Date
ATA266377A true ATA266377A (en) 1980-09-15
AT362057B AT362057B (en) 1981-04-27

Family

ID=5975638

Family Applications (1)

Application Number Title Priority Date Filing Date
AT266377A AT362057B (en) 1976-04-17 1977-04-15 METHOD FOR ENRICHING THE PLAZENTA-SPECIFIC PROTEIN PP 5

Country Status (20)

Country Link
JP (1) JPS52154509A (en)
AT (1) AT362057B (en)
AU (1) AU517434B2 (en)
BE (1) BE853711A (en)
CA (1) CA1101847A (en)
CH (2) CH630643A5 (en)
DE (1) DE2616984C3 (en)
DK (1) DK168577A (en)
ES (2) ES457714A1 (en)
FI (1) FI60875C (en)
FR (1) FR2348222A1 (en)
GB (1) GB1555197A (en)
IE (1) IE44824B1 (en)
IL (1) IL51883A (en)
IT (1) IT1075832B (en)
LU (1) LU77143A1 (en)
NL (1) NL7703963A (en)
NO (1) NO146747C (en)
NZ (1) NZ183878A (en)
SE (1) SE7704359L (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2640387C3 (en) * 1976-09-08 1981-01-22 Behringwerke Ag, 3550 Marburg Tissue-specific protein and method for its production
DE2720704C2 (en) * 1977-05-07 1986-09-25 Behringwerke Ag, 3550 Marburg New glycoprotein, process for its production and its uses
DE2745680A1 (en) * 1977-10-11 1979-04-12 Behringwerke Ag CONTRACEPTIVE MEANS
DE3071972D1 (en) * 1979-11-02 1987-06-25 Theurer Karl Process for concentration of tumor-inhibiting substances
DE3013724A1 (en) 1980-04-10 1981-10-15 Behringwerke Ag, 3550 Marburg NEW PROTEIN PP (DOWN ARROW) 9 (DOWN ARROW), METHOD FOR ITS ENRICHMENT AND PRODUCTION AND ITS USE
DE3334405A1 (en) * 1983-09-23 1985-04-04 Behringwerke Ag, 3550 Marburg MEMBRANE ASSOCIATED PROTEINS (MP (DOWN ARROW) 2 (DOWN ARROW)), METHOD FOR THEIR EXTRACTION AND USE
NZ212523A (en) * 1985-06-24 1989-01-06 Univ Massey Mobile phase for purification of proteins by high performance liquid chromatography
US20030220233A1 (en) 1994-01-24 2003-11-27 Neorx Corporation Radiolabeled annexins
US5968477A (en) 1994-01-24 1999-10-19 Neorx Corporation Radiolabeled annexin conjugates with hexose and a chelator
CA2190727C (en) * 1994-05-19 2006-07-18 Sudhakar Kasina Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
US6005083A (en) 1997-03-28 1999-12-21 Neorx Corporation Bridged aromatic substituted amine ligands with donor atoms

Also Published As

Publication number Publication date
IE44824L (en) 1977-10-17
DE2616984B2 (en) 1981-01-29
NO771316L (en) 1977-10-18
ES462699A1 (en) 1978-07-01
DK168577A (en) 1977-10-18
GB1555197A (en) 1979-11-07
ES457714A1 (en) 1978-02-16
FR2348222A1 (en) 1977-11-10
BE853711A (en) 1977-10-18
CH630643A5 (en) 1982-06-30
DE2616984C3 (en) 1981-10-29
SE7704359L (en) 1977-10-18
AU2431977A (en) 1978-10-19
LU77143A1 (en) 1977-11-14
FI771186A (en) 1977-10-18
DE2616984A1 (en) 1977-10-20
IL51883A0 (en) 1977-06-30
NO146747C (en) 1982-12-01
IT1075832B (en) 1985-04-22
NZ183878A (en) 1980-04-28
IE44824B1 (en) 1982-04-07
IL51883A (en) 1980-02-29
AT362057B (en) 1981-04-27
FR2348222B1 (en) 1980-02-08
NL7703963A (en) 1977-10-19
NO146747B (en) 1982-08-23
AU517434B2 (en) 1981-07-30
FI60875C (en) 1982-04-13
CA1101847A (en) 1981-05-26
FI60875B (en) 1981-12-31
JPS52154509A (en) 1977-12-22
CH632091A5 (en) 1982-09-15

Similar Documents

Publication Publication Date Title
AT380695B (en) METHOD FOR PRODUCING A SELECTED PROTEIN
DD130037A5 (en) METHOD FOR PRODUCING AMINO ALKYLHETEROCYCLES
AT359217B (en) METHOD FOR PRODUCING NEW PEPTIDE DERIVATIVES
DD148464A3 (en) METHOD FOR OBTAINING L-THREONINE
AT373577B (en) METHOD FOR PRODUCING NEW MERCAPTOACYL PEPTIDES
AT364095B (en) METHOD FOR PRODUCING NEW PEPTIDE DERIVATIVES
AT365929B (en) METHOD FOR OBTAINING A NEW TISSUE-SPECIFIC PROTEIN
AT359022B (en) METHOD FOR PRODUCING A STABILIZED GLUCOSEISOMERASE ENZYME CONCENTRATE
ATA266377A (en) METHOD FOR ENRICHING A PLAZENTA-SPECIFIC PROTEIN PP 5
AT363205B (en) METHOD FOR PRODUCING NEW DIPEPTIDE DERIVATIVES
ATA60577A (en) METHOD FOR PRODUCING NEW POLYPEPTIDE DERIVATIVES
AT355741B (en) METHOD FOR PRODUCING NEW DIPEPTIDE DERIVATIVES
AT367769B (en) METHOD FOR PURIFYING PROTEINS
AT359197B (en) METHOD FOR PRODUCING PHARMACEUTICAL PREPARATIONS
AT366062B (en) METHOD FOR OBTAINING A NEW PROTEIN
AT365417B (en) METHOD FOR PRODUCING A PROTEIN CONCENTRATE
AT351672B (en) METHOD FOR OBTAINING IV-COMPATIBLE GAMMAGLOBULINES
AT369034B (en) METHOD FOR DETERMINING TRANSAMINASES
AT352921B (en) METHOD FOR PRODUCING NEW DIPEPTIDE DERIVATIVES
AT358689B (en) METHOD FOR REPRODUCTING IMAGES
AT343125B (en) METHOD FOR PREPARING 3-PHENYLPYRIDAZONE- (6)
DD131530A5 (en) METHOD FOR CONTAINING OIL AND PROTEIN S
ATA619377A (en) METHOD FOR OBTAINING ARISTOLOCHIAS ACIDS
AT358515B (en) METHOD FOR PREPARING A PROTEIN CONCENTRATE
ATA185977A (en) METHOD FOR PRODUCING A SERUM PROTEIN PREPARATION

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee